Diag-Nose.io Projected to Enhance Global Respiratory Care Markets Following Oversubscribed $2M Seed Funding
Diag-Nose.io, a trailblazer in biotechnology and a distinguished graduate from Stanford University’s EENT Innovation Biodesign program, proudly announces the closure of an oversubscribed $2M seed funding round.